Herein, by conducting IHC of 20 non-tumoral brains and 120 gliomas with detailed clinical features, we confirmed the upregulation of Pontin in glioma and verified its positive correlation with advanced glioma grade, high proliferation index and short patient survival. This evidence concerns the gene RUVBL1 and central nervous system cancer.